MITACS: Multivalent Immune TArgeting synthetic Chimeric therapeuticS. Ghent University
Exploiting nature’s own defense mechanisms to eliminate target proteins or cells is an attractive therapeutic avenue. In this project we aim to leverage this therapeutic potential by developing Multivalent Immune TArgeting synthetic Chimeric therapeuticS, i.e. MITACS, which are synthetic chimeric molecules that bind to target proteins or cells and flags them for destruction by endogenous mechanisms. Focusing on an onco-immunological context, ...